Parmax Pharma
PARMAXBSE

Parmax Pharma

₹37.000.76 (2.10%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
33.16
Today’s high
38.85
52 week low
22.60
52 week high
47.84
Open price
36.06
Previous close
36.24
Live volume
3,478
Lower circuit
29.00
Upper circuit
43.48

Fundamentals

Market Cap
₹14Cr
ROE
75.76%
P/E Ratio(TTM)
--
EPS(TTM)
-13.55
P/B Ratio
0.00
Dividend Yield
0.00%
Industry P/E
45.26
Book Value
-14.81
Debt to Equity
-2.38
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
DEC '25
Revenue (Cr)
₹4.34
+70.87%
Profit (Cr)
-₹0.73
+64.90%
-5-1.2503.757.5
Dec '24
Mar '25
Jun '25
Sep '25
Dec '25
Revenue growthValue
1Y (TTM)-31%
3Y CAGR+16%
Profit growthValue
1Y (TTM)-47%

About

Parmax Pharma Limited manufactures pharmaceutical formulations, including tablets, capsules, and ointments.;
CEO/MD
Dr. Umang A. Gosalia
Founded in
1994
BSE symbol
540359

Shareholding Pattern

Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Retail And Others
69.20%
Promoters
30.80%

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
Innova CaptabINNOVACAP
₹855.05
+6.75 (0.80%)
L
    H
    4,853.8234.444.45
    ₹389.35
    +20.65 (5.60%)
    L
      H
      4,019.1884.0215.2
      Orchid PharmaORCHPHARMA
      ₹715.35
      +8.85 (1.25%)
      L
        H
        3,590.91190.322.82
        ₹369.15
        -12.30 (3.22%)
        L
          H
          3,570.02354.54
          Recent news is not available for this stock
          2026
          14
          Feb
          Quarterly Result
          Release date
          2025
          14
          Nov
          Quarterly Result
          Release date
          14
          Aug
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks